Top Markets
Coin of the day
Amniotics AB (publ) Amniotics AB (publ)

Amniotics AB (publ)

AMNI
株式のランク #37511
Amniotics AB (publ) specializes in the creation, manufacturing, and... Amniotics AB (publ) specializes in the creation, manufacturing, and commercialization of stem cell-based therapies, utilizing mesenchymal stem cells to address critical, life-threatening illnesses. The company's primary therapeutic candidate, PulmoStem, is designed for the treatment of inflammatory and fibrotic conditions affecting the lungs. Furthermore, Amniotics is advancing other promising treatments such as CogniStem for neurological disorders, NephroStem for kidney-specific ailments, and CutiStem for various dermatological issues. Beyond its own pipeline, the firm provides contract development and manufacturing services for advanced therapy medicinal products to pharmaceutical companies, universities, and hospitals. Established in 2015, Amniotics AB is headquartered in Lund, Sweden.
株価
$0.00060315
最終同期: 2024-09-27
時価総額
$1.65M
変化(1日)
19.64%
変化(1年)
0.00%
SE
取引 Amniotics AB (publ) (AMNI)

カテゴリー

Amniotics AB (publ)(AMNI)のEPS
December 2023 時点のEPS TTM: $-0.04
Amniotics AB (publ)の最新の財務報告と株価によると、同社の現在のEPS(TTM)は$-0.04です。2022年末には、EPSは$-0.03で、2021年のEPS$-0.04と減少でした。
Amniotics AB (publ)のEPS履歴(2018から2026まで)
各年末時点のEPS
EPS 変化
2026 (TTM) $-0.04 -96.18%
2023 0.00 -96.18%
2022 $-0.03 -21.10%
2021 $-0.04 77.18%
2020 $-0.02 237.70%
2019 $-0.01 45.24%
2018 0.00 0.00%
同様の企業または競合他社のEPS
企業 EPS EPSの差
$17.32 -47,293.46%
US
$27.74 -75,685.83%
NL
- -
CH
- -
KR
$13.70 -37,429.97%
BE